Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.

BACKGROUND/OBJECTIVES:Inflammatory biomarkers have been associated with stroke and mortality, but inflammation may also have detrimental effects beyond acute events. We hypothesized that serum concentrations of interleukin-6 (IL6) and lipoprotein-associated phospholipase A2 (LpPLA2) were inversely a...

Full description

Bibliographic Details
Main Authors: Mandip S Dhamoon, Ying-Kuen Cheung, Yeseon P Moon, Clinton B Wright, Ralph L Sacco, Mitchell S V Elkind
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0214784
_version_ 1818403721531359232
author Mandip S Dhamoon
Ying-Kuen Cheung
Yeseon P Moon
Clinton B Wright
Ralph L Sacco
Mitchell S V Elkind
author_facet Mandip S Dhamoon
Ying-Kuen Cheung
Yeseon P Moon
Clinton B Wright
Ralph L Sacco
Mitchell S V Elkind
author_sort Mandip S Dhamoon
collection DOAJ
description BACKGROUND/OBJECTIVES:Inflammatory biomarkers have been associated with stroke and mortality, but inflammation may also have detrimental effects beyond acute events. We hypothesized that serum concentrations of interleukin-6 (IL6) and lipoprotein-associated phospholipase A2 (LpPLA2) were inversely associated with long-term functional decline independently of vascular risk factors, stroke and myocardial infarction (MI) occurring during follow-up. DESIGN:Prospective population based cohort study. SETTING:The Northern Manhattan Study. PARTICIPANTS (INCLUDING THE SAMPLE SIZE):Race/ethnically diverse stroke-free individuals in northern Manhattan aged ≥40 years (n = 3298). INTERVENTION:None. MEASUREMENTS:Annual functional assessments with the Barthel index (BI), for a median of 13 years. BI was analyzed as a continuous variable (range 0-100). Baseline demographics, risk factors, and laboratory studies were collected, including IL6 (n = 1679), LpPLA2 mass (n = 1912) and activity (n = 1937). Separate mixed models estimated standardized associations between each biomarker and baseline functional status and change over time, adjusting for demographics, vascular risk factors, social variables, cognition, and depression measured at baseline, and stroke and MI occurring during follow-up. RESULTS:Mean age was 69 (SD 10) years, 35% were male, 53% Hispanic, 74% hypertensive, and 16-24% diabetic. LogIL6 was associated with decline in BI over time (-0.13 points per year, 95% CI -0.24, -0.02) and marginally with baseline BI (-0.20, 95% CI -0.40, 0.01). LpPLA2 activity levels were associated with baseline BI (-0.36, 95% CI -0.68, -0.04) but not change over time, and LpPLA2 mass levels were not associated with either. CONCLUSION:In this large population-based study, higher serum inflammatory biomarker levels were associated with disability, even when adjusting for baseline covariates and stroke and MI occurring during follow-up.
first_indexed 2024-12-14T08:28:46Z
format Article
id doaj.art-3b46cd119b424ef58d6a5d625bd1f8c5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:28:46Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3b46cd119b424ef58d6a5d625bd1f8c52022-12-21T23:09:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01144e021478410.1371/journal.pone.0214784Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.Mandip S DhamoonYing-Kuen CheungYeseon P MoonClinton B WrightRalph L SaccoMitchell S V ElkindBACKGROUND/OBJECTIVES:Inflammatory biomarkers have been associated with stroke and mortality, but inflammation may also have detrimental effects beyond acute events. We hypothesized that serum concentrations of interleukin-6 (IL6) and lipoprotein-associated phospholipase A2 (LpPLA2) were inversely associated with long-term functional decline independently of vascular risk factors, stroke and myocardial infarction (MI) occurring during follow-up. DESIGN:Prospective population based cohort study. SETTING:The Northern Manhattan Study. PARTICIPANTS (INCLUDING THE SAMPLE SIZE):Race/ethnically diverse stroke-free individuals in northern Manhattan aged ≥40 years (n = 3298). INTERVENTION:None. MEASUREMENTS:Annual functional assessments with the Barthel index (BI), for a median of 13 years. BI was analyzed as a continuous variable (range 0-100). Baseline demographics, risk factors, and laboratory studies were collected, including IL6 (n = 1679), LpPLA2 mass (n = 1912) and activity (n = 1937). Separate mixed models estimated standardized associations between each biomarker and baseline functional status and change over time, adjusting for demographics, vascular risk factors, social variables, cognition, and depression measured at baseline, and stroke and MI occurring during follow-up. RESULTS:Mean age was 69 (SD 10) years, 35% were male, 53% Hispanic, 74% hypertensive, and 16-24% diabetic. LogIL6 was associated with decline in BI over time (-0.13 points per year, 95% CI -0.24, -0.02) and marginally with baseline BI (-0.20, 95% CI -0.40, 0.01). LpPLA2 activity levels were associated with baseline BI (-0.36, 95% CI -0.68, -0.04) but not change over time, and LpPLA2 mass levels were not associated with either. CONCLUSION:In this large population-based study, higher serum inflammatory biomarker levels were associated with disability, even when adjusting for baseline covariates and stroke and MI occurring during follow-up.https://doi.org/10.1371/journal.pone.0214784
spellingShingle Mandip S Dhamoon
Ying-Kuen Cheung
Yeseon P Moon
Clinton B Wright
Ralph L Sacco
Mitchell S V Elkind
Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
PLoS ONE
title Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
title_full Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
title_fullStr Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
title_full_unstemmed Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
title_short Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.
title_sort interleukin 6 and lipoprotein associated phospholipase a2 are associated with functional trajectories
url https://doi.org/10.1371/journal.pone.0214784
work_keys_str_mv AT mandipsdhamoon interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories
AT yingkuencheung interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories
AT yeseonpmoon interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories
AT clintonbwright interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories
AT ralphlsacco interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories
AT mitchellsvelkind interleukin6andlipoproteinassociatedphospholipasea2areassociatedwithfunctionaltrajectories